baber/WOPTO huggingface dataset:
Patent NZ-337311-A (NZ)
Title: A method of reconstituting a non-human animal embryo by nuclear transfer of quiescent cells into a recipient cell
Inventor: CAMPBELL KEITH HENRY STOCKMAN
IPC: A61K35/54
Filed: 1996-08-30
Abstract: Disclosed is a method of reconstituting a non-human mammalian embryo, the method comprising fusing a quiescent diploid donor cell with an enucleated oocyte or microinjecting a quiescent diploid donor cell into an enucleated oocyte. Also disclosed is a non-human mammalian embryo prepared by the method.
Patent NZ-337909-A (NZ)
Title: Power transmission cable with impact-resistant expanded polymer coating
Inventor: BELLI SERGIO
IPC: H01B7/00
Filed: 1998-05-08
Abstract: A power transmission cable comprises an inner structure and a coating layer disposed to surround the inner structure.  The coating layer is made from an expanded polymer material having a degree of expansion of 20-3000% and a flexural modulus of at least 200MPa measured at room temperature according to ASTM standard D790 before expansion of the polymer.
Patent NZ-503823-A (NZ)
Title: Amide derivatives and their use in treating retinal neurodegenerative disorders
Inventor: FUJIBAYASHI TATSUYA
IPC: C07C235/46
Filed: 1998-10-22
Abstract: A medicament for treating retinal neurodegenerative disorder comprising a compound of the given formula wherein, Ar is optionally substituted phenyl or optionally substituted aromatic heterocyclic group; N is 0, 1 or 2; R1 is H, optionally substituted alkyl, optionally substituted alkenyl, alkoxycarbonyl, carbamoyl, alkanoyl or cyano; R2 and R3 are independently optionally substituted alkyl; or any two groups of R1, R2 and R3 may be taken together with the carbon atom adjacent thereto to form cycloalkane or all of R1, R2 and R3 may be taken together with the carbon atom adjacent thereto to form bicycloalkane or tricycloalkane, wherein the cycloalkane, the bicycloalkane and the tricycloalkane may be optionally substituted; R4 and R5 are independently H or optionally substituted alkyl; and R6 is H, hydroxy or alkyl. Compounds of formula (I) wherein Ar2 is a group of formula (II) or a six membered aromatic heterocyclic group substituted by 1 to 3 halogen atoms; R1, R2, R3 and R6 are as defined above; One of R7 and R8 is a fluorine atom; The other is H or a halogen atom; and R9 is a H or halogen atom provided that the compound is not one of the following compounds: N-t-butyl-4-fluorobenzamide, N-t-butyl-2-fluorobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-2,4,5-trifluorobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-2,5-difluorobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-2-fluorobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-5-chloro-2-fluorobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-2-chloro-6-iodobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-2,6-difluorobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-2-chloro-4-fluorobenzamide, N-t-butyl-3-chloro-2-pyridincarboxamide, or N-(2-hydroxy-1,1-dimethylethyl)-6-chloro-2-pyridinecarboxamide.
Patent NZ-504505-A (NZ)
Title: Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants
Inventor: FREYSSINET GEORGES
IPC: C07K19/00
Filed: 1998-11-06
Abstract: A DNA sequence coding for thanatin, a vector containing it for transforming a host organism and the transformation method.  Also described is the transformation of plant cells and plants by a vector containing a DNA sequence coding for thanatin.  The thanatin produced by the plants provides them with resistance to diseases, particularly diseases of fungal origin.
Patent NZ-505204-A (NZ)
Title: A method for protecting a sensor using a composition comprising glucose and sucrose
Inventor: RICHTER JACOB
IPC: A61B5/00
Filed: 1998-12-16
Abstract: A method for protecting a remotely monitorable sensor from damage during insertion into and fixation in a bodily lumen, comprising the step of applying a soluble protective layer to the sensor, wherein the protective layer dissolves after insertion and fixation to allow proper operation of the sensor. The sensor (1) has two holes (3) in its periphery for attachment to sutures within a lumen. A coronary artery (5) starting at the aorta (7) and having an occlusion (9), a bypass (11) is connected between the aorta at point (13) and at point (15) beyond the occlusion (9). A sensor (1) is placed either at the proximal ostium (17) or at the proximal part of the bypass (19). The sensor (1) is fixed in place using the two holes (3) for attachment to the sutures. The soluble protective layer comprises glucose and sucrose of approximately equal proportions.
Patent NZ-509282-A (NZ)
Title: Improved rake
Inventor: MITCHELL DAVID
IPC: A01D7/10
Filed: 2000-02-09
Abstract: A rake made of a first rake part having a handle and a first rake head section connected to one end of the handle, and a second rake part having a second rake head section. The section rake part is detachably connected to the first rake part in a manner to have the first and second rake head sections form a full rake head. The second rake part is detachable from the first rake part for use alone, or with the first rake part to grasp a pile of debris.
Patent NZ-511703-A (NZ)
Title: Tool support
Inventor: RUSSELL ALLAN GRANT
IPC: B21D5/02
Filed: 2001-05-15
Abstract: A tool support, for a hand-held tool adapted to rotate a working head, the support including, a) a main body, and b) an anchor element located at one end of said main body adapted to pivotally connect the main body to a support surface or element, and c) a tool connector located at another end of said body, the tool connector being adapted to pivotally connect the hand-held tool to the main body, wherein the support is configured to transfer torque applied by the hand-held tool through the tool connector, and main body to the anchor element.
Patent NZ-511747-A (NZ)
Title: Regulatory/unfolding peptides of ezrin
Inventor: HOLMS RUPERT DONALD
IPC: C07K14/16
Filed: 2000-09-15
Abstract: An isolate peptide having an amino acid sequence of at least 5 amino acids identical to a portion of amino acids 333-355 of the Hepreceptor for example: MREKEELMLRLQDY(p)EEKTKKAERELSEQIQRALQ
Patent NZ-512311-A (NZ)
Title: Detection of mycobacterium avium subspecies
Inventor: VAN MAANEN CORNELIS
IPC: C12Q1/689
Filed: 1999-12-03
Abstract: The invention relates to the field of microbiology, more specifically to the field of detection and identification of pathogenic micro-organisms, more specifically to the detection and identification of Mycobacterium avium subspecies paratuberculosis, an agent which causes Johne's disease in many ruminants. The invention provides a method by which a rapid and sensitive procedure for the detection and identification of Mycobacterium avium subspecies paratuberculosis in biological and natural samples is achieved, whereby Mycobacterium avium subspecies paratuberculosis can be discriminated from other Mycobacterium avium subspecies, such as subspecies avium.
Patent NZ-512836-A (NZ)
Title: RTE cereals and other foods presweetened with D tagatose
Inventor: HOWLING DAVID
IPC: A23L7/10
Filed: 2000-01-14
Abstract: Processes to prepare a ready to eat (RTE) cereal having a sugar coating comprising D tagatose, either alone or in combination with at least one polyol. D tagatose can be used for a sweetener in other foodstuffs, including functional and convenience foods, as well as in the mentioned RTE cereals. The foods are pre-sweetened with a syrup solution comprising D tagatose, either alone or in combination with at least one polyol.
Patent NZ-513525-A (NZ)
Title: Aromatic heterocyclic urea and thiourea derivatives, pharmaceuticals thereof and their use as antiinflammatory agents
Inventor: CIRILLO PIER F
IPC: A61P19/10
Filed: 1999-12-09
Abstract: A compound of formula (I) where: Ar1 is thiophene or pyrazole; Ar2 is 1-napthyl; L is a linking group which is a C1-6 saturated or unsaturated, branched or unbranched carbon chain wherein one or more methylene groups are optionally independently replaced by O, N or S; and Q is as defined as disclosed. The use of a compound of formula (I) for treatment of inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, Guillain-Barre syndrome, Crohn's disease, ulcerative colitis, psoriasis, graft versus host disease and type I diabetes.
Patent NZ-515943-A (NZ)
Title: Solid fuel stove with means to maintain secondary combustion chamber temperature for clean burning of fuel
Inventor: BEST ROGER JOHN
IPC: F24B1/24
Filed: 2001-12-05
Abstract: A solid fuel stove, which includes, a receiver adapted to receive fuel burnt and provided with a grate spaced above the base thereof. Means for supplying primary combustion air to the upper portion of the fuel receiver such that the primary combustion air is drawn through the fuel in the receiver to a primary combustion zone in the vicinity of the grate. A secondary combustion zone opens out from the first, which includes a chamber lined with heat retaining refractory material and being connected to one end of a gas outlet flue. Also included is means for supplying secondary combustion air to the secondary combustion zone and means to heat the zone to, or greater than a predetermined temperature.
Patent NZ-526330-A (NZ)
Title: Benzimidazole and pyridylimidazole derivatives
Inventor: LI GUIYING
IPC: C07D403/04
Filed: 2001-12-21
Abstract: Benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds, all of which may be described by of Formula A. The invention is particularly related to such compounds that bind with high selectivity and high affinity to the benzodiazepine site of GABAA receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in treatment of certain central nervous system (CNS) diseases. Novel processes for preparing compounds of Formula A are disclosed. This invention also relates to the use of benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds of Formula A in combination with one or more other CNS agents to potentiate the effects of the other CNS agents. Additionally this invention relates to the use such compounds as probes for the localization of GABAA receptors in tissue sections.
Patent NZ-530592-A (NZ)
Title: Pole mounting system having base with upstanding ear(s) welded to base of pole
Inventor: MITCHELL JAMES
IPC: E02D27/42
Filed: 2002-06-26
Abstract: A pole mounting system that comprises:- (a) A base plate having a top, bottom and an opening; (b) At least one ear extending upwardly from the base plate adjacent to the opening and terminating in an upper edge; and (c) A pole having a lower end terminating in a lower edge, the lower end being received within the opening and being secured thereto by a weld along the upper edge of each ear. Whereby the base plate provides structural support to the pole.
Patent NZ-534035-A (NZ)
Title: Strengthening means
Inventor: NEWMAN ALAN HARRY
Filed: 2004-07-09
Abstract: A metal pan of the type having an overlying flange at one edge and an underlying flange at the other edge; the underlying flange of one pan in use being adapted to nest under an overlying flange of another pan; said metal pan having attached to its overlying flange a separate strengthening member shaped to increase the compressive strength of the nested flanges in use.
Patent NZ-534665-A (NZ)
Title: Data structure for user modification of metadata in a shell browser
Inventor: KURTZ JAMES BRIAN
IPC: G06F40/00
Filed: 2003-04-01
Abstract: A computer-readable media has stored thereon a data structure containing metadata associated with one or more items displayed in a shell browser. The data structure comprises a first field containing user modifiable metadata associated with the one or more displayed items. The user modifiable metadata contained in the first field of the data structure is also displayed in the shell browser and the shell browser is part of a computer operating system. (62) Divided Out of 525094
Patent NZ-539008-A (NZ)
Title: Composition for vaccination by transdermal delivery
Inventor: KIRKBY NIKOLAI SOREN
IPC: A61K39/39
Filed: 2003-10-02
Abstract: A construct for transdermal delivery of at least one immunogen comprises at least one immunogen, on occlusion vehicle and an immunogen delivery system. The immunogen delivery system is a complex comprising: i) at least one first sterol and/or at least one second sterol, wherein the second sterol is capable of contacting a genetic determinant by means of an interaction selected from electrostatic interaction and a hydrophobic interaction and wherein the first sterol and/or the second sterol is capable of forming a complex with at least one first saponin and/or at least one second saponin; ii) at least one first sapion and/or at least one second saponin wherein the second saponin is capable of contacting a genetic determinant by means of an interaction selected from electrostatic interaction and a hydrophobic interaction and wherein the first saponin and/or the second saponin is capable of forming a complex with at one least first sterol and/or at least one second sterol, and optionally; iii) at least one contacting group for contacting a genetic determinant by means of an interaction selected from electrostatic interaction and a hydrophobic interaction, with the proviso that the at least one contacting group is present when no second sterol is present in the complex, and further optionally; iv) at least one lipophilic moiety. The construct can be used in the manufacture of a medicament for generating an immunological response in an individual.
Patent NZ-544638-A (NZ)
Title: Multi-dose inhaler
Inventor: LULLA AMAR
IPC: A61M15/00
Filed: 2004-07-09
Abstract: A medicament inhaler 2 with automatic dosage indexing and presentation includes top 4 and bottom 6 body portions rotatable relative to one another and designed for receiving a medicament cartridge disc 12 comprising a plurality of compartments containing medicament. A medicament extraction spike 14 is located adjacent a compartment. When the user rotates the top and bottom body portions from a storage position to a use position a cartridge compartment is advanced into alignment with the spike and then pierced by the spike to allow medicament inhalation by a user. The spiral torsion spring 16 mounted within drum 18 and in the top portion serves to bias the advance the disc so that the next cartridge is aligned with the spike. Two pins 34 are each secured to the top portion and each is movable between an extended position, in which the respective pin is engageable with a received cartridge so as to limit the cartridge advancement caused by said spring, and a retracted position, in which the respective pin is spaced from a received cartridge so as to not limit cartridge advancement.
Patent NZ-545808-A (NZ)
Title: 1-Carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof
Inventor: GALLOU ISABELLE
IPC: C07C229/48
Filed: 2004-08-12
Abstract: Disclosed is a process for preparing a compound of formula (Ic), comprising (a) alkylating a cyanoester of formula NC-CH2COOR1 with a base and a cycloalkylating agent to make a cycloalkyl cyanoester, and (b) performing base hydrolysis on the product of step (a) with a suitable base.
Patent NZ-546614-A (NZ)
Title: Automatic dosage unit
Inventor: MALYKKE TORBEN
IPC: A47J42/40
Filed: 2004-12-22
Abstract: An automatic dosage unit (1) comprising a storage unit (2), a closing device (6), a conic grinder (10) driven by an electric motor (9), an identification unit (5), a funnel (8), a fastening/locking device (7), and a vibration-suppression mounting means (35), arranged to grind a programmed amount of a given product directly into a specific collection unit (4). For example, in connection with the storage unit being filled with coffee beans, a caffetier is inserted into the fastening mechanism, whereupon the dosage unit automatically registers the size of the caffetier and a pre-programmed amount of coffee is ground directly into the caffetier. Thus the dosage unit has the features that it can identify the size of the collection unit, that the product is ground directly into the collection unit by means of a hollow drive shaft, that the storage unit is opened upon installation and closed upon de-installation on the dosage unit, as well as that the collection unit is fastened to the dosage unit for the entire duration of the grinding process.
Patent NZ-563997-A (NZ)
Title: Cutting insert that is double-sided and indexable
Inventor: SMILOVICI CAROL
IPC: B23C5/02
Filed: 2006-06-07
Abstract: A double-sided reversible and indexable cutting insert is disclosed. The cutting insert comprises identical opposing first and second end faces (28) and a peripheral side surface (32) extending there between. A clamping through-bore (38) extends between, and opening out to, the first and second end faces. The cutting insert has a median plane extending between the first and second end faces and a through-bore axis extending perpendicularly through the median plane as well as having a Y-fold rotational symmetry about the through-bore axis. The peripheral side surface comprises of Y major side surfaces (34) and Y minor side surfaces, each minor side surfaces interconnecting two adjacent major side surfaces (34). Each minor side surface is a section of a single cylindrical surface having a given radius (R), the given radius (R) is greater than a minor side surface distance (D) of each minor side surface from the through-bore axis.
Patent NZ-565191-A (NZ)
Title: Watermelon line 100-1005
Inventor: BARHAM ROBERT
IPC: A01H5/08
Filed: 2008-01-17
Abstract: Disclosed is a seed of a watermelon line 110-1005, wherein a sample of the seed of watermelon line 110-1005 was deposited under ATCC Accession Number PTA-7957. Also disclosed is a method for producing said seed.
Patent NZ-576110-A (NZ)
Title: Hydrobenzamide derivatives as inhibitors of hsp90
Inventor: FREDERICKSON MARTYN
IPC: A61P35/00
Filed: 2007-10-12
Abstract: Disclosed is the acid addition lactic acid salt of (2,4-dihydroxy-5-isopropyl-phenyl)-[5-(4-methyl-piperazin-1-ylmethyl)-1,3-dihydro-isoindol-2-yl]-methanone, represented by general formula (1). The process for making the compound of formula (1) as well as processes for making the intermediates are also disclosed. Also disclosed is the use of the salt of the compound of formula (1) for treating a disease or condition comprising or arising from abnormal cell growth in a mammal; for treating cancer, pain, for preventing or reducing neuronal damage in a patient suffering from stroke, for the prevention or reduction of risk of stroke in patients at risk for stroke; for the prophylaxis or treatment of a viral infection or viral disease; for blocking or inhibiting viral replication in a host organism; for sensitizing malignant cells to an anticancer drug; for alleviating or reducing the incidence of resistance to an anticancer drug; for reversing resistance to an anticancer drug; for potentiating the activity of an anticancer drug.
Patent NZ-584069-A (NZ)
Title: Piloted poppet valve with angled valve members contacting complementary valve seating surfaces simultaneously
Inventor: NEFF ROBERT H
IPC: F16K39/02
Filed: 2010-03-18
Abstract: A valve assembly includes a valve body having a valve bore. A valve member is slidably disposed within the valve bore between first and second stop positions. First and second valve elements of the valve member have first and second sealing surfaces equally angled with respect to a valve member longitudinal axis. Each of the first and second sealing surfaces is oriented parallel with conical shaped first and second seat surfaces. Both first and second seat surfaces are equally angled with respect to the longitudinal axis and have an adjustable spacing such that the first sealing surface contacts the first seat surface and the second sealing surface contacts the second seat surface simultaneously in the first stop position.
Patent NZ-584340-A (NZ)
Title: Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
Inventor: O'NEIL DEBORAH
IPC: A61K38/04
Filed: 2005-08-18
Abstract: Provided is the use of a peptide or pharmaceutically acceptable salt thereof comprising polylysine having between 3 and 200 lysine amino acids in the manufacture of a medicament for the treatment of a fungal infection of a human or animal body. The infection can be tinea, candidiasis, histoplasmosis, blastomycosis, aspergillosis or onychomycosis. (62) Divided Out of 553494
Patent NZ-585701-A (NZ)
Title: Benzopyrazine derivatives as prolyl hydroxylase inhibitors
Inventor: COLON MARIELA
IPC: A61K31/498
Filed: 2008-11-26
Abstract: Disclosed are 6-hydroxy benzopyrazine / quinoxaline derivatives as represented by the general formula (I), wherein R' is NR6R7 or OR8; R2, R3, R4 and R5 are each independently selected from the group consisting of hydrogen, nitro, cyano, halogen, -C(O)R11, C(O)OR11, OR11, SR11, S(O)R11, S(O)2R11, NR9R10, CONR9R10, N(R9)C(O)R11, N(R9)C(O)OR11, OC(O)NR9R10, N(R9)C(O)N9R10, P(O)(OR11)2, SO2NR9R10, N(R9)SO2R11, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkenyl, aryl, and heteroaryl; and wherein the remaining substituents are as defined herein. Representative compounds include N-[(6-hydroxy-3-phenyl-5-quinoxalinyl)carbonyl] glycine; N-{ [7-(3,5-difluorophenyl)-6-hydroxy-5-quinoxalinyl]carbonyl} glycine; N-[(3-(3,4-difluorophenyl)-6-hydroxy-7- { 3-[(1-methylethyl)oxy]phenyl} -5-quinoxalinyl)carbonyl]glycine; N-{ [2-(3-fluorophenyl)-6-hydroxy-5-quinoxalinyl]carbonyl} glycine; N-{ [8-(2-furanyl)-6-hydroxy-5-quinoxalinyl]carbonyl} glycine; N-{ [6-hydroxy-8-(1,3-thiazol-5-yl)-5-quinoxalinyl]carbonyl} glycine and N-{ [6-hydroxy-2-(3-pyridinyl)-5-quinoxalinyl]carbonyl} glycine. Further disclosed is a pharmaceutical composition which comprises a compound of formula (I) or a salt, solvate, as defined above and one or more of pharmaceutically acceptable carriers, diluents and excipients for treating anaemia.
Patent NZ-587618-A (NZ)
Title: Sensing unit for sagnac optical fibre current sensor and a current sensor
Inventor: HAYWOOD JOHN
IPC: G01C19/72
Filed: 2009-02-20
Abstract: 587618 Disclosed is a sensing unit for a Sagnac interferometer current sensor (13). The sensing unit has a sensing coil (14) with an optical fibre that is arranged in use to transmit a single elliptical polarisation state. The sensing coil has first (15) and second (16) loops that are interconnected such that light propagating in a first direction in the first loop (15) will propagate in a second, opposite, direction in the second loop (16). The first (15) and second (16) loops are wound with turns and enclosed areas that satisfy the relationship: N1xA1=N2xA2, whereN1 is the number of turns in the first loop (15), A1 is the area enclosed by the first loop (15), N2 is number of turns in the second loop (16) and A2is area enclosed by the second loop (16). A carrier is included having first (11) and second (12) conductor portions that are arranged such that a current flow will effectively be in opposite directions through the first (11) and second (12) conductor portions. The first (15) and the second (16) interconnected loops in use enclose the respective first (11) and second (12) current conductor portions.
Patent NZ-587695-A (NZ)
Title: Transportation device such as a roller skate or skateboard with a pivoting axle contacting curved surface
Inventor: KORTSCHOT MARK TIMOTHY
IPC: A63C17/01
Filed: 2009-03-06
Abstract: Devices and methods of transport, typically for a roller skate or skateboard, are disclosed. Various embodiments include structural aspects related to steering and changing the direction of conveyances including features which utilize leaning or shifting of weight as part of turning. In one aspect there is provided a curved surface 122 for contacting axle 36.